Isolate Data
Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
HSH2 | H-SH2-W22 | France | 2008 | HIV1 | B | Plasma | None |
Treatment History
Order | Regimen | Weeks |
1 | PI+RTI | NA |
2 | RAL | 22 |
Integrase Sequence
INIMajorDRMs | INIMinorDRMs | Polys | UnusualMuts |
G140S, Q148H | G163R | S17N, R20K, L28I, S39C, T124A, T125A, V201I, I208L | G70R |
>H-SH2-W22| codons 1-288 FLDGIDKAQEEHEKYHNNWKAMASDFNIPPVVAKEIVACCDKCQLKGEAMHGQVDCSPGI WQLDCTHLERKIILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSN FTSAAVKAACWWAGIKQEFSIPYNPQSHGVVESMNKELKKIIRQVRDQAEHLKTAVQMAV FIHNFKRKGGIGGYSAGERIIDIIATDLQTKELQKQITKIQNFRVYYRDSRDPLWKGPAK LLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED |
References
Author | Title | Citation |
Malet, I | Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro. | AAC, 2008 |